An experimental new treatment slows down the spread of metastatic prostate cancer, postponing the use of hormone treatment by ...

For the first time, patients whose prostate cancer has not spread will be eligible for the drug abiraterone in England, after NHS chiefs widened access to the treatment. Around 2,000 men diagnosed ...

Current guidelines for clinically localized prostate cancer offer a wide range of management options, from active surveillance to surgery and radiation therapy (RT). Treatment selection depends on ...